These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 108343)

  • 41. Genetic studies on resistant and susceptibility genes controlling the mouse cornea to infection with Pseudomonas aeruginosa.
    Berk RS; Hazlett LD; Beisel KW
    Antibiot Chemother (1971); 1987; 39():83-91. PubMed ID: 3674828
    [No Abstract]   [Full Text] [Related]  

  • 42. [Mechanism of bacteriopyknosis].
    Pal'tsyn AA; Kolokol'chikova EG; Badikova AK; Chervonskaia NV; Grishina IA
    Biull Eksp Biol Med; 1997 Mar; 123(3):349-52. PubMed ID: 9162255
    [No Abstract]   [Full Text] [Related]  

  • 43. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are biofilms the answer in the pathophysiology and treatment of chronic rhinosinusitis?
    Kilty SJ; Desrosiers MY
    Immunol Allergy Clin North Am; 2009 Nov; 29(4):645-56. PubMed ID: 19879440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A.
    Tan RM; Kuang Z; Hao Y; Lee F; Lee T; Lee RJ; Lau GW
    Infect Immun; 2015 Apr; 83(4):1339-46. PubMed ID: 25605768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Passive immunisation against Gram-negative bacilli in burns.
    Jones RJ
    Br J Exp Pathol; 1970 Feb; 51(1):53-8. PubMed ID: 4985031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.
    Robinson CM; Kobe BN; Schmitt DM; Phair B; Gilson T; Jung JY; Roberts L; Liao J; Camerlengo C; Chang B; Davis M; Figurski L; Sindeldecker D; Horzempa J
    Bioengineered; 2015; 6(2):82-8. PubMed ID: 25617059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 17β-Estradiol Dysregulates Innate Immune Responses to Pseudomonas aeruginosa Respiratory Infection and Is Modulated by Estrogen Receptor Antagonism.
    Abid S; Xie S; Bose M; Shaul PW; Terada LS; Brody SL; Thomas PJ; Katzenellenbogen JA; Kim SH; Greenberg DE; Jain R
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa.
    Lorè NI; Cigana C; Riva C; De Fino I; Nonis A; Spagnuolo L; Sipione B; Cariani L; Girelli D; Rossi G; Basso V; Colombo C; Mondino A; Bragonzi A
    Sci Rep; 2016 May; 6():25937. PubMed ID: 27189736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model.
    Kwong MS; Evans DJ; Ni M; Cowell BA; Fleiszig SM
    Infect Immun; 2007 May; 75(5):2325-32. PubMed ID: 17325054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of protective effects of chitin, chitosan, and N-acetyl chitohexaose against Pseudomonas aeruginosa and Listeria monocytogenes infections in mice.
    Okawa Y; Kobayashi M; Suzuki S; Suzuki M
    Biol Pharm Bull; 2003 Jun; 26(6):902-4. PubMed ID: 12808311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
    Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptional profiles of pulmonary innate immune responses to isogenic antibiotic-susceptible and multidrug-resistant Pseudomonas aeruginosa.
    Tam VH; Pérez C; Ledesma KR; Lewis RE
    Microbiol Immunol; 2018 Apr; 62(4):291-294. PubMed ID: 29418013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BCG-induced susceptibility of mice to challenge with Pseudomonas aeruginosa.
    Lal S; Mitsuyama M; Ogata N; Miyata M; Miake S; Nomoto K
    J Gen Microbiol; 1983 Jan; 129(1):93-8. PubMed ID: 6403661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa Infection.
    Merches K; Khairnar V; Knuschke T; Shaabani N; Honke N; Duhan V; Recher M; Navarini AA; Hardt C; Häussinger D; Tümmler B; Gulbins E; Futerman AH; Hoffmann D; Lang F; Lang PA; Westendorf AM; Lang KS
    Cell Physiol Biochem; 2015; 36(6):2379-92. PubMed ID: 26279441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model.
    von Köckritz-Blickwede M; Rohde M; Oehmcke S; Miller LS; Cheung AL; Herwald H; Foster S; Medina E
    Am J Pathol; 2008 Dec; 173(6):1657-68. PubMed ID: 18974303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigations in mice on the potentiation of resistance to infections by a new immunostimulant compound.
    Bicker U; Ziegler AE; Hebold G
    J Infect Dis; 1979 Apr; 139(4):389-95. PubMed ID: 374647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity.
    Py BF; Gonzalez SF; Long K; Kim MS; Kim YA; Zhu H; Yao J; Degauque N; Villet R; Ymele-Leki P; Gadjeva M; Pier GB; Carroll MC; Yuan J
    Immunity; 2013 May; 38(5):1063-72. PubMed ID: 23684986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.